Effect of cordycepin on the expression of the inflammatory cytokines TNF-alpha, IL-6, and IL-17a in C57bL/6 mice

Journal of Microbiology and Biotechnology

Volumn 23, Issue 2, 2013, Pages 156-160

  Seo, Min Jeong ^a   Kim, Min Jeong ^a   Lee, Hye Hyeon ^a   Park, Jeong Uck ^a   Kang, Byoung Won ^a   Kim, Gi Young ^b   Rhu, En Ju ^c   Kim, Jung In ^d   Kim, Kwang Hyuk ^e   Jeong, Yong Kee ^a  

^a Dong A University   (South Korea)

^b Jeju National University   (South Korea)

^c Hanseo University   (South Korea)

^d Inje University   (South Korea)

^e Kosin University College of Medicine   (South Korea)

Author keywords

Cordycepin; IL 17a; IL 6; Splenocytes; TNF

Indexed keywords

CORDYCEPIN; INTERLEUKIN 17; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL;

EID: 84873860162     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1211.11032     Document Type: Article

References (32)

1. Arican, O., M. Aral, S. Sasmaz, and P. Ciragil. 2005. Serum levels of TNF-α, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 24: 273.
2. Bhagat, K. and P. Vallance. 1997. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96: 3042-3047.
3. Bok, J. W., L. Lermer, J. Chilton, H. G. Klingeman, and G. H. Towers. 1999. Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 51: 891-898.
4. Boguniewicz, M., R. J. Martin, D. Martin, U. Gibson, A. Celniker, M. Williams, and Y. M. Donald. 1995. The effects of nebulized recombinant interferon-gamma in asthmatic airways. J. Allergy Clin. Immunol. 95: 133-135.
5. Borish, L. C. and J. W. Steinke. 2003. Cytokines and chemokines. J. Allergy Clin. Immunol. 111: S460-S475.
6. Cho, M. A., D. S. Lee, M. J. Kim, J. M. Sung, and S. S. Ham. 2003. Antimutagenicity and cytotoxicity of cordycepin isolated from Cordyceps militaris. Food Sci. Biotechnol. 12: 472-475.
7. Choi, S. B., C. H. Park, M. K. Choi, D. W. Jun, and S. M. Park. 2004. Improvement of insulin resistance and insulin secretion by water extracts of Cordyceps militaris, Phellinus linteus, and Paecilomyces tenuipes in 90% pancreatectomized rats. Biosci. Biotechnol. Biochem. 68: 2257-2264.
8. Cunningham, K. G., W. Manson, F. S. Spring, and S. A. Hutchinson. 1950. Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.). Nature 166: 949.
9. Edrees, A. F., S. N. Misra, and N. I. Abdou. 2005. Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: Correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions. Clin. Exp. Rheumatol. 23: 469.
10. Ito, H. 2003. IL-6 and Crohn's disease. Curr. Drug Targets Inflamm. Allergy 2: 125.
11. Jeong, M. H., M. J. Seo, J. U. Park, B. W. Kang, K. S. Kim, J. Y. Lee, et al. 2012. Effect of cordycepin purified from Cordyceps militaris on Th1 and Th2 cytokines in mouse splenocytes. J. Microbiol. Biotechnol. 22: 1161-1164.
12. Kodama, E. N., R. P. McCaffrey, K. Yusa, and H. Mitsuya. 2000. Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells. Biochem. Pharmacol. 59: 273-281.
13. Lack, G., H. S. Nelson, D. Amran, A. Oshiba, T. Jung, K. L. Bradley, et al. 1997. Rush immunotherapy results in allergenspecific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells. J. Allergy Clin. Immunol. 99: 530-538.
14. Li, S. P., P. Li, C. M. Lai, Y. X. Gong, K. W. Kan, T. X. Dong, et al. 2004. Simultaneous determination of ergosterol, nucleosides and their bases from natural and cultured Cordyceps by pressurised liquid extraction and high-performance liquid chromatography. J. Chromatgr. A 1036: 239-243.
15. Lundberg, I., A. K. Ulfgren, P. Nyberg, U. Andersson, and L. Klareskog. 1997. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 40: 865-874.
16. Müller, W. E., B. E. Weiler, R. Charubala, W. Pfleiderer, L. Leserman, R. W. Sobol, et al. 1991. Cordycepin analogues of 2', 5'-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase. Biochemistry 30: 2027-2033.
17. Naka, T., N. Nishimoto, and T. Kishimoto. 2002. The paradigm of IL-6: From basic science to medicine. Arthritis Res. 4: S233-S242.
18. Nakamura, K., K. Konoha, N. Yoshikawa, Y. Yamaguch, S. Kagota, K. Shinozuka, and M. Kunitomo. 2005. Effect of cordycepin (3'-deoxyadenosine) on hematogenic lung metastatic model mice. In Vivo 19: 137-141.
19. Nakamura, K., N. Yoshikawa, Y. Yamaguchi, S. Kagota, K. Shinozuka, and M. Kunitomo. 2006. Antitumor effect of cordycepin (3'-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. Anticancer Res. 26: 43-48.
20. Old, L. J. 1985. Tumor necrosis factor (TNF). Science 230: 630-632.
21. Osuchowski, M. F., K. Welch, J. Siddiqui, and D. G. Remick. 2006. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177: 1967-1974.
22. Rook, A. H., H. Masur, H. C. Lane, W. Frederick, T. Kasahara, A. M. Macher, et al. 1983. Interleukin-2 enhances the depressed natural killer and CMV specific cytotoxic activation of lymphocytes from patients with the acquired immunodeficiency syndrome. J. Clin. Invest. 72: 398-403.
23. Ruffolo, C., M. Scarpa, D. Faggian, A. Pozza, F. Navaglia, R. D'Incà, et al. 2008. Cytokine network in rectal mucosa in perianal Crohn's disease: Relations with inflammatory parameters and need for surgery. Inflamm. Bowel Dis. 14: 1406.
24. Schoenborn, J. R. and C. B. Wilson. 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 96: 41-101.
25. Smith, K. A., L. B. Lachman, J. J. Oppenheim, and M. F. Favata. 1980. The functional relationship of the interleukins. J. Exp. Med. 151: 1551-1556.
26. Smolen, J. S. and R. N. Maini. 2006. Interleukin-6: A new therapeutic target. Arthritis Res. Ther. 8 (Suppl 2): S5.
27. Sugar, A. M. and R. P. McCaffrey. 1998. Antifungal activity of 3-deoxyadenosine (cordycepin). Antimicrob. Agents Chemother. 42: 1424-1427.
28. Thomadaki, H., A. Scorilas, C. M. Tsiapalis, and M. Havredaki. 2008. The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: Implication of polyadenylation in a cell type specific manner. Cancer Chemother. Pharmacol. 61: 251-265.
29. Yu, R., W. Yang, L. Song, C. Yan, Z. Zhang, and Y. Zhao. 2007. Structural characterization and antioxidant activity of a polysaccharide from the fruiting bodies of cultured Cordyceps militaris. Carbohydr. Polym. 70: 430-436.
30. Yun, Y. H., S. H. Han, S. J. Lee, S. K. Ko, C. K. Lee, N. J. Ha, and K. J. Kim. 2003. Anti-diabetic effects of CCCA, cmESS, and cordycepin from Cordyceps militaris and the immune responses in streptozotocin-induced diabetic mice. Nat. Prod. Sci. 9: 291-298.
31. Yoo, H. S., J. W. Shin, J. H. Cho, C. G. Son, Y. W. Lee, S. Y. Park, and C. K. Cho. 2004. Effect of Cordyceps militaris extract on angiogenesis and tumor growth. Acta Pharmacol. Sin. 25: 657-665.
32. Zhou, X., C. U. Meyer, P. Schmidtke, and F. Zepp. 2002. Effect of cordycepin on interleukin-10 production of human peripheral blood mononuclear cells. Eur. J. Pharmacol. 453: 309-317.